Chorionic villus sampling, a prenatal test to identify genetic disorders in fetuses, does not increase the risk of high blood pressure, or pre-eclampsia, in pregnant women, according to U.K. researchers. In a study of more than 31,000 pregnant women, those who underwent CVS had similar rates of pre-eclampsia as those who did not get the test, the researchers found.

Full Story:

Related Summaries